IL-11 has also been suggested as a diagnostic marker for NSCLC in bronchoalveolar lavage fluid, serum, and exhaled-breath condensates [19,20], and a potential blood biomarker in NSCLC, although the screening sensitivity remains a limitation (as discussed in [21]). This evidence concerns the gene IL11 and non-small cell lung carcinoma.